{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T20:33:36Z","timestamp":1792960416645,"version":"4.5.0"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Biomaterialia"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.actbio.2026.10.034","type":"journal-article","created":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:04:42Z","timestamp":1792685082000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Optimizing the co-assembly of hydrophobic amino acid-modified hexahistidine and bevacizumab for near-complete inhibition of corneal neovascularization"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-1775-1715","authenticated-orcid":false,"given":"Wenlian","family":"Ye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-2128-5320","authenticated-orcid":false,"given":"Tianfang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bojiao","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuexi","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanna","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-6406-9901","authenticated-orcid":false,"given":"Jin","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0492-2913","authenticated-orcid":false,"given":"Xingjie","family":"Zan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-2783-5724","authenticated-orcid":false,"given":"Lisha","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.actbio.2026.10.034_bib0001","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/00055735-200108000-00002","article-title":"Corneal neovascularization","volume":"12","author":"Chang","year":"2001","journal-title":"Curr. Opin. Ophthalmol."},{"key":"10.1016\/j.actbio.2026.10.034_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2020.108363","article-title":"Corneal neovascularization","volume":"202","author":"Nicholas","year":"2021","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.actbio.2026.10.034_bib0003","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.brainresbull.2009.05.019","article-title":"Corneal transparency: genesis, maintenance and dysfunction","volume":"81","author":"Qazi","year":"2010","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.actbio.2026.10.034_bib0004","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.exer.2004.09.013","article-title":"Corticosteroids inhibit VEGF-induced vascular leakage in a rabbit model of blood-retinal and blood-aqueous barrier breakdown","volume":"80","author":"Edelman","year":"2005","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.actbio.2026.10.034_bib0005","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s40662-017-0094-6","article-title":"Therapeutic approaches for corneal neovascularization","volume":"4","author":"Feizi","year":"2017","journal-title":"Eye Vis."},{"key":"10.1016\/j.actbio.2026.10.034_bib0006","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1097\/ICO.0b013e318201405a","article-title":"Treatments for corneal neovascularization: a review","volume":"30","author":"Gupta","year":"2011","journal-title":"Cornea"},{"key":"10.1016\/j.actbio.2026.10.034_bib0007","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.survophthal.2012.01.007","article-title":"Corneal neovascularization: an anti-VEGF therapy review","volume":"57","author":"Chang","year":"2012","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.actbio.2026.10.034_bib0008","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/ICO.0b013e318159019f","article-title":"Subconjunctival bevacizumab injection for corneal neovascularization","volume":"27","author":"Bahar","year":"2008","journal-title":"Cornea"},{"key":"10.1016\/j.actbio.2026.10.034_bib0009","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1001\/archophthalmol.2009.18","article-title":"Topical bevacizumab in the treatment of corneal neovascularization: results of a prospective, open-label, noncomparative study","volume":"127","author":"Dastjerdi","year":"2009","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.actbio.2026.10.034_bib0010","doi-asserted-by":"crossref","first-page":"6748","DOI":"10.1016\/j.biomaterials.2013.05.045","article-title":"Construction of tissue-engineered cornea composed of amniotic epithelial cells and acellular porcine cornea for treating corneal alkali burn","volume":"34","author":"Luo","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2026.10.034_bib0011","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jconrel.2014.06.043","article-title":"Ocular delivery of macromolecules","volume":"190","author":"Kim","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.actbio.2026.10.034_bib0012","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jtos.2018.06.004","article-title":"Current and emerging therapies for corneal neovascularization","volume":"16","author":"Roshandel","year":"2018","journal-title":"Ocul. Surf."},{"key":"10.1016\/j.actbio.2026.10.034_bib0013","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1517\/17425247.5.5.567","article-title":"Ocular novel drug delivery: impacts of membranes and barriers","volume":"5","author":"Barar","year":"2008","journal-title":"Expert. Opin. Drug. Deliv."},{"key":"10.1016\/j.actbio.2026.10.034_bib0014","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ejpb.2012.02.014","article-title":"Novel micelle carriers for cyclosporin A topical ocular delivery: in vivo cornea penetration, ocular distribution and efficacy studies","volume":"81","author":"Di Tommaso","year":"2012","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.actbio.2026.10.034_bib0015","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.actbio.2019.03.058","article-title":"Hexahistidine-metal assemblies: A promising drug delivery system","volume":"90","author":"Huang","year":"2019","journal-title":"Acta Biomater."},{"key":"10.1016\/j.actbio.2026.10.034_bib0016","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.actbio.2021.05.001","article-title":"Efficient delivery of cytosolic proteins by protein-hexahistidine-metal co-assemblies","volume":"129","author":"Huang","year":"2021","journal-title":"Acta Biomater."},{"key":"10.1016\/j.actbio.2026.10.034_bib0017","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.actbio.2025.02.006","article-title":"A promising strategy for ocular noninvasive protein delivery: The case in treating corneal neovascularization","volume":"196","author":"Mao","year":"2025","journal-title":"Acta Biomater."},{"key":"10.1016\/j.actbio.2026.10.034_bib0018","article-title":"Deliver protein across bio-barriers via hexa-histidine metal assemblies for therapy: a case in corneal neovascularization model","volume":"12","author":"Xu","year":"2021","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.actbio.2026.10.034_bib0019","article-title":"Combined delivery of small molecule and protein drugs as synergistic therapeutics for treating corneal neovascularization by a one-pot coassembly strategy","volume":"17","author":"Huang","year":"2022","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.actbio.2026.10.034_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2019.107697","article-title":"In vivo effect of bevacizumab-loaded albumin nanoparticles in the treatment of corneal neovascularization","volume":"185","author":"Luis De Redin","year":"2019","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.actbio.2026.10.034_bib0021","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jconrel.2011.04.019","article-title":"A method for enhancing the ocular penetration of eye drops using nanoparticles of hydrolyzable dye","volume":"153","author":"Baba","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.actbio.2026.10.034_bib0022","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1016\/j.nano.2016.05.017","article-title":"Physicochemical properties of core-shell type nanoparticles govern their spatiotemporal biodistribution in the eye","volume":"12","author":"Mahaling","year":"2016","journal-title":"Nanomedicine"},{"key":"10.1016\/j.actbio.2026.10.034_bib0023","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000055638","article-title":"Effect of particle size of polymeric nanospheres on intravitreal kinetics","volume":"33","author":"Sakurai","year":"2001","journal-title":"Ophthalmic Res."},{"key":"10.1016\/j.actbio.2026.10.034_bib0024","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jconrel.2017.07.035","article-title":"Novel nanosystems for the treatment of ocular inflammation: Current paradigms and future research directions","volume":"268","author":"Lalu","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.actbio.2026.10.034_bib0025","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1002\/smll.201303433","article-title":"Topical delivery of Avastin to the posterior segment of the eye in vivo using annexin A5-associated liposomes","volume":"10","author":"Davis","year":"2014","journal-title":"Small"},{"key":"10.1016\/j.actbio.2026.10.034_bib0026","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev-bioeng-071811-150124","article-title":"The effect of nanoparticle size, shape, and surface chemistry on biological systems","volume":"14","author":"Albanese","year":"2012","journal-title":"Annu. Rev. Biomed. Eng."},{"key":"10.1016\/j.actbio.2026.10.034_bib0027","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/nmat2202","article-title":"Surface-structure-regulated cell-membrane penetration by monolayer-protected nanoparticles","volume":"7","author":"Verma","year":"2008","journal-title":"Nat. Mater."},{"key":"10.1016\/j.actbio.2026.10.034_bib0028","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abq3104","article-title":"Eyedrop-based macromolecular ophthalmic drug delivery for ocular fundus disease treatment","volume":"9","author":"Shen","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.actbio.2026.10.034_bib0029","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.actbio.2017.09.023","article-title":"Discerning the composition of penetratin for safe penetration from cornea to retina","volume":"63","author":"Jiang","year":"2017","journal-title":"Acta Biomater."},{"key":"10.1016\/j.actbio.2026.10.034_bib0030","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.actbio.2022.09.029","article-title":"Decorating hexahistidine-metal assemblies with tyrosine enhances the ability of proteins to pass through corneal biobarriers","volume":"153","author":"Tang","year":"2022","journal-title":"Acta Biomater."},{"key":"10.1016\/j.actbio.2026.10.034_bib0031","doi-asserted-by":"crossref","first-page":"37065","DOI":"10.1021\/acsnano.5c10610","article-title":"Highly efficient intrastromal dual-drug delivery by a dissolving bilayer microneedle for synergistic therapy against corneal neovascularization","volume":"19","author":"Zhang","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.actbio.2026.10.034_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.122081","article-title":"An injectable thermosensitive hydrogel for dual delivery of diclofenac and Avastin to effectively suppress inflammatory corneal neovascularization","volume":"625","author":"Shi","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.actbio.2026.10.034_bib0033","doi-asserted-by":"crossref","first-page":"4205","DOI":"10.1039\/C8TB00312B","article-title":"A facile and efficient strategy to encapsulate the model basic protein lysozyme into porous CaCO3","volume":"6","author":"Shi","year":"2018","journal-title":"J. Materials Chem. B"},{"key":"10.1016\/j.actbio.2026.10.034_bib0034","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.colsurfb.2018.11.079","article-title":"Insight into the mechanism and factors on encapsulating basic model protein, lysozyme, into heparin doped CaCO3","volume":"175","author":"Shi","year":"2019","journal-title":"Colloids Surfaces B-Biointerfaces"},{"key":"10.1016\/j.actbio.2026.10.034_bib0035","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202301771","article-title":"pH-responsive hexa-histidine metal assembly (HmA) with Enhanced biocatalytic cascades as the vehicle for glucose-mediated long-acting insulin delivery","volume":"10","author":"Zhou","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.actbio.2026.10.034_bib0036","doi-asserted-by":"crossref","first-page":"8209","DOI":"10.1021\/acsnano.3c12203","article-title":"Engineering matrix-free drug protein nanoparticles with promising penetration through biobarriers for treating corneal neovascularization","volume":"18","author":"Xu","year":"2024","journal-title":"Acs Nano"},{"key":"10.1016\/j.actbio.2026.10.034_bib0037","doi-asserted-by":"crossref","first-page":"3993","DOI":"10.1529\/biophysj.103.038422","article-title":"Automatic and quantitative measurement of protein-protein colocalization in live cells","volume":"86","author":"Costes","year":"2004","journal-title":"Biophys. J."},{"key":"10.1016\/j.actbio.2026.10.034_bib0038","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1365-2818.1993.tb03313.x","article-title":"Measurement of co-localization of objects in dual-colour confocal images","volume":"169","author":"Manders","year":"1993","journal-title":"J. Microsc."},{"key":"10.1016\/j.actbio.2026.10.034_bib0039","doi-asserted-by":"crossref","first-page":"4012","DOI":"10.1021\/acsbiomaterials.0c00218","article-title":"Evaluation of His6-metal assemblies as a drug delivery vehicle in the treatment of anterior segment disease using a corneal inflammation model","volume":"6","author":"Wang","year":"2020","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.actbio.2026.10.034_bib0040","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000268009","article-title":"Combined non-steroidal therapy in experimental corneal injury","volume":"29","author":"Laria","year":"1997","journal-title":"Ophthalmic Res."},{"key":"10.1016\/j.actbio.2026.10.034_bib0041","doi-asserted-by":"crossref","first-page":"14777","DOI":"10.1074\/jbc.M108967200","article-title":"Chronic ethanol increases lipopolysaccharide-stimulated Egr-1 expression in RAW 264.7 macrophages: contribution to enhanced tumor necrosis factor alpha production","volume":"277","author":"Shi","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.actbio.2026.10.034_bib0042","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1186\/s12951-023-01992-2","article-title":"Nanotechnology-based ocular drug delivery systems: recent advances and future prospects","volume":"21","author":"Li","year":"2023","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.actbio.2026.10.034_bib0043","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1021\/acs.molpharmaceut.0c00212","article-title":"Hexahistidine-Metal assemblies: a facile and effective codelivery system of subunit vaccines for potent humoral and cellular immune responses","volume":"17","author":"Zhang","year":"2020","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.actbio.2026.10.034_bib0044","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nrm3176","article-title":"Molecular control of endothelial cell behaviour during blood vessel morphogenesis","volume":"12","author":"Herbert","year":"2011","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"10.1016\/j.actbio.2026.10.034_bib0045","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1161\/01.RES.0000259593.07661.1e","article-title":"Endothelial cell migration during angiogenesis","volume":"100","author":"Lamalice","year":"2007","journal-title":"Circ. Res."},{"key":"10.1016\/j.actbio.2026.10.034_bib0046","doi-asserted-by":"crossref","first-page":"4218","DOI":"10.1039\/C6CS00636A","article-title":"Cellular uptake of nanoparticles: journey inside the cell","volume":"46","author":"Behzadi","year":"2017","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.actbio.2026.10.034_bib0047","doi-asserted-by":"crossref","first-page":"3814","DOI":"10.1021\/bm301281k","article-title":"Endocytic uptake and intracellular trafficking of bis-MPA-based hyperbranched copolymer micelles in breast cancer cells","volume":"13","author":"Zeng","year":"2012","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.actbio.2026.10.034_bib0048","doi-asserted-by":"crossref","first-page":"4665","DOI":"10.1096\/fj.201700336R","article-title":"Animal models of ocular angiogenesis: from development to pathologies","volume":"31","author":"Liu","year":"2017","journal-title":"FASEB J."},{"key":"10.1016\/j.actbio.2026.10.034_bib0049","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1096\/fasebj.13.1.9","article-title":"Vascular endothelial growth factor (VEGF) and its receptors","volume":"13","author":"Neufeld","year":"1999","journal-title":"Faseb J."},{"key":"10.1016\/j.actbio.2026.10.034_bib0050","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nm0603-669","article-title":"The biology of VEGF and its receptors","volume":"9","author":"Ferrara","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.actbio.2026.10.034_bib0051","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1038\/nm.3668","article-title":"PDGF-BB secreted by preosteoclasts induces angiogenesis during coupling with osteogenesis","volume":"20","author":"Xie","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.actbio.2026.10.034_bib0052","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.bbrc.2005.04.135","article-title":"Human adipose tissue-derived stem cells differentiate into endothelial cells in vitro and improve postnatal neovascularization in vivo","volume":"332","author":"Cao","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.actbio.2026.10.034_bib0053","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1039\/C8TB03034K","article-title":"Designing nanoparticles with improved tumor penetration: surface properties from the molecular architecture viewpoint","volume":"7","author":"Zhang","year":"2019","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.actbio.2026.10.034_bib0054","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.apsb.2016.09.001","article-title":"Nanotechnology-based strategies for treatment of ocular disease","volume":"7","author":"Weng","year":"2017","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.actbio.2026.10.034_bib0055","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1023\/A:1013061926851","article-title":"Predicted permeability of the cornea to topical drugs","volume":"18","author":"Edward","year":"2001","journal-title":"Pharm. Res."},{"key":"10.1016\/j.actbio.2026.10.034_bib0056","doi-asserted-by":"crossref","first-page":"3556","DOI":"10.1021\/mp500332m","article-title":"On the barrier properties of the cornea: a microscopy study of the penetration of fluorescently labeled nanoparticles, polymers, and sodium fluorescein","volume":"11","author":"Mun","year":"2014","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.actbio.2026.10.034_bib0057","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/j.drudis.2019.02.001","article-title":"Design principles of ocular drug delivery systems: importance of drug payload, release rate, and material properties","volume":"24","author":"Subrizi","year":"2019","journal-title":"Drug. Discov. Today"},{"key":"10.1016\/j.actbio.2026.10.034_bib0058","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1023\/A:1008741731244","article-title":"The influence of lipophilicity on the pharmacokinetic behavior of drugs: Concepts and examples","volume":"19","author":"Testa","year":"2000","journal-title":"Perspect. Drug. Discov."},{"key":"10.1016\/j.actbio.2026.10.034_bib0059","article-title":"Enhanced ocular delivery of Beva via ultra-small polymeric micelles for noninvasive anti-VEGF therapy","volume":"36","author":"Yang","year":"2024","journal-title":"Advanced Materials"},{"key":"10.1016\/j.actbio.2026.10.034_bib0060","article-title":"Size-evolving protein drug nanoparticles: a promising non-invasive strategy for retinal neovascularization by overcoming multiple ocular barriers","volume":"36","author":"Xie","year":"2026","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.actbio.2026.10.034_bib0061","doi-asserted-by":"crossref","DOI":"10.1186\/s12951-026-04775-7","article-title":"Size-shrinking nanoparticles with high drug-protein payload for efficient, non-invasive treatment of corneal neovascularization","volume":"24","author":"Xie","year":"2026","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.actbio.2026.10.034_bib0062","doi-asserted-by":"crossref","first-page":"44205","DOI":"10.1039\/D0RA08947H","article-title":"Melting properties of amino acids and their solubility in water","volume":"10","author":"Do","year":"2020","journal-title":"Rsc Adv."},{"key":"10.1016\/j.actbio.2026.10.034_bib0063","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1021\/js950474+","article-title":"Comparative in vitro evaluation of several colloidal systems, nanoparticles, nanocapsules, and nanoemulsions, as ocular drug carriers","volume":"85","author":"Calvo","year":"1996","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.actbio.2026.10.034_bib0064","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1021\/nn406018q","article-title":"Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles","volume":"8","author":"Walkey","year":"2014","journal-title":"ACS Nano"},{"key":"10.1016\/j.actbio.2026.10.034_bib0065","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/nsb1096-842","article-title":"Experimentally determined hydrophobicity scale for proteins at membrane interfaces","volume":"3","author":"Wimley","year":"1996","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.actbio.2026.10.034_bib0066","doi-asserted-by":"crossref","DOI":"10.1002\/marc.202170025","article-title":"Indole, Phenyl, and Phenol Groups: The Role of the Comonomer on Gene Delivery in Guanidinium Containing Methacrylamide Terpolymers","volume":"42","author":"Hack","year":"2021","journal-title":"Macromol. Rapid Commun."},{"key":"10.1016\/j.actbio.2026.10.034_bib0067","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1529\/biophysj.105.080275","article-title":"Indole localization in lipid membranes revealed by molecular simulation","volume":"91","author":"Norman","year":"2006","journal-title":"Biophys. J."},{"key":"10.1016\/j.actbio.2026.10.034_bib0068","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.cell.2008.11.044","article-title":"Bidirectional transport of amino acids regulates mTOR and autophagy","volume":"136","author":"Nicklin","year":"2009","journal-title":"Cell"}],"container-title":["Acta Biomaterialia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706126007142?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706126007142?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T19:47:36Z","timestamp":1792957656000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1742706126007142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":68,"alternative-id":["S1742706126007142"],"URL":"https:\/\/doi.org\/10.1016\/j.actbio.2026.10.034","relation":{},"ISSN":["1742-7061"],"issn-type":[{"value":"1742-7061","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimizing the co-assembly of hydrophobic amino acid-modified hexahistidine and bevacizumab for near-complete inhibition of corneal neovascularization","name":"articletitle","label":"Article Title"},{"value":"Acta Biomaterialia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actbio.2026.10.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Acta Materialia Inc. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}